Evaluation of an Infant Immunization Encouragement Program in Nigeria
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Polio
Related studies linked through entity extraction aliases.
Environmental Surveillance (ES) for Polio and AMR Using the TaqMan Array Card
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of Integrating MIYCN Interventions in Existing CGPP of PCI
- Status
- COMPLETED
- Phase
- NA
Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan
- Status
- UNKNOWN
- Phase
- NA
Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants
- Status
- COMPLETED
- Phase
- PHASE4
DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants
- Status
- COMPLETED
- Phase
- PHASE3
OPV Transmissibility in Communities After Cessation of Routine OPV Immunization
- Status
- COMPLETED
- Phase
- NA
Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life
- Status
- COMPLETED
- Phase
- PHASE2
Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan
- Status
- COMPLETED
- Phase
- PHASE4
To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan
- Status
- UNKNOWN
- Phase
- PHASE4
Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine
- Status
- UNKNOWN
- Phase
- PHASE4
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Polio NID and Routine EPI Integration Trial Pakistan
- Status
- COMPLETED
- Phase
- NA
Pakistan Short Interval mOPV1 Compared With Standard Interval mOPV1 and bOPV 1,3
- Status
- COMPLETED
- Phase
- NA
Evaluation of Buffer on Immune Response to Oral Polio Vaccine (OPV) in Bangladesh
- Status
- COMPLETED
- Phase
- NA
Diarrhea and Bivalent Oral Polio Vaccine Immunity
- Status
- COMPLETED
- Phase
- NA
Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China
- Status
- COMPLETED
- Phase
- PHASE4
Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine
- Status
- COMPLETED
- Phase
- PHASE4
Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan
- Status
- COMPLETED
- Phase
- PHASE3
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3